<p>(A) Human RPECs were incubated with TNF-α for the indicated time intervals. The protein expression of ICAM-1 was determined by Western blot. (B, C) Cells were incubated with TNF-α (15 ng/ml) for the indicated time intervals. The mRNA levels and promoter activity of ICAM-1 were determined by real-time PCR and promoter assay, respectively. (D) RPECs were pretreated with an ICAM-1 neutralizing antibody for 1 h, and then incubated with TNF-α for 6 h. The THP-1 cells adherence was measured. Data are expressed as mean±S.E.M. of three independent experiments. <sup><i>*</i></sup><i>P</i><0.05; <sup>#</sup><i>P</i><0.01, as compared with the cells exposed to vehicle alone (A-C) or TNF-α alone (D).</p
AbstractUnstimulated human fibroblasts show low or undetectable ICAM-1 expression. Interferon-beta (...
Bone marrow mesenchymal stem/stromal cells (BM-MSCs) have immunoregulatory capacity; therefore, they...
<p>(<b>A</b>) Flow cytometric analysis indicating Tat (14.4 nM)-mediated changes in ALCAM, ICAM & VC...
<p>(A) Human RPECs were pretreated with a TNFR neutralizing antibody, and then incubated with TNF-α ...
<p>(A) Cells were pretreated with Ro318220, Rottlerin, or Gӧ6976 for 1 h, and then incubated with TN...
<p>TNF-α-induced ICAM-1 expression and monocyte adhesion are mediated through a TNFR1/TRAF2/PKCδ/JNK...
TNF-alpha induced an increase in intercellular adhesion molecule-1 (ICAM- 1) expression in human A54...
<p>(A) HUVECs were pretreated with R1R2 or scramble peptide before treatment with TNF-α (10ng/ml) fo...
ICAM-1 is a cell surface glycoprotein originally defined by a monoclonal antibody (MAb) that inhibit...
<p>) At 70% confluence, HMVECLs cells pretreated with 10 ng/ml TNFα to induce ICAM-1 expression. At ...
<p>(A) HAECs were treated with 50 ng/ml TNF-α and lysates were collected at 0, 10, 30 and 60 minutes...
<p>(A) Confluent HUVECs were stimulated with rTp0965 (800 ng/ml) for 24 h. Monocyte THP-1 cells stai...
Interferon-gamma (IFN-gamma) induced intercellular adhesion molecule-1 ( ICAM-1) expression in human...
<p>ICAM-1 expression on (A) non-transduced PC and (B) ICAM-1-transduced PC (ICAM-1+PC) monolayers fo...
<p><b>A</b>) real time RT-PCR of ICAM-1 or VCAM-1 mRNA expression by CASMCs stimulated with TNFα or ...
AbstractUnstimulated human fibroblasts show low or undetectable ICAM-1 expression. Interferon-beta (...
Bone marrow mesenchymal stem/stromal cells (BM-MSCs) have immunoregulatory capacity; therefore, they...
<p>(<b>A</b>) Flow cytometric analysis indicating Tat (14.4 nM)-mediated changes in ALCAM, ICAM & VC...
<p>(A) Human RPECs were pretreated with a TNFR neutralizing antibody, and then incubated with TNF-α ...
<p>(A) Cells were pretreated with Ro318220, Rottlerin, or Gӧ6976 for 1 h, and then incubated with TN...
<p>TNF-α-induced ICAM-1 expression and monocyte adhesion are mediated through a TNFR1/TRAF2/PKCδ/JNK...
TNF-alpha induced an increase in intercellular adhesion molecule-1 (ICAM- 1) expression in human A54...
<p>(A) HUVECs were pretreated with R1R2 or scramble peptide before treatment with TNF-α (10ng/ml) fo...
ICAM-1 is a cell surface glycoprotein originally defined by a monoclonal antibody (MAb) that inhibit...
<p>) At 70% confluence, HMVECLs cells pretreated with 10 ng/ml TNFα to induce ICAM-1 expression. At ...
<p>(A) HAECs were treated with 50 ng/ml TNF-α and lysates were collected at 0, 10, 30 and 60 minutes...
<p>(A) Confluent HUVECs were stimulated with rTp0965 (800 ng/ml) for 24 h. Monocyte THP-1 cells stai...
Interferon-gamma (IFN-gamma) induced intercellular adhesion molecule-1 ( ICAM-1) expression in human...
<p>ICAM-1 expression on (A) non-transduced PC and (B) ICAM-1-transduced PC (ICAM-1+PC) monolayers fo...
<p><b>A</b>) real time RT-PCR of ICAM-1 or VCAM-1 mRNA expression by CASMCs stimulated with TNFα or ...
AbstractUnstimulated human fibroblasts show low or undetectable ICAM-1 expression. Interferon-beta (...
Bone marrow mesenchymal stem/stromal cells (BM-MSCs) have immunoregulatory capacity; therefore, they...
<p>(<b>A</b>) Flow cytometric analysis indicating Tat (14.4 nM)-mediated changes in ALCAM, ICAM & VC...